| Literature DB >> 28395745 |
Wasinee Wongkummool1, Warun Maneepitasut2, Pirut Tong-Ngam3, Amornrat Tangprasittipap4, Thongperm Munkongdee5, Chanikarn Boonchuay6, Saovaros Svasti7, Narisorn Kitiyanant3, Kittiphong Paiboonsukwong5, Suthat Fucharoen5, Alisa Tubsuwan8.
Abstract
The thalassemias are a group of genetic disorders characterized by a deficiency in the synthesis of globin chains. In this study the MUi009-A human induced pluripotent stem cell line was successfully generated from peripheral blood CD34+ haematopoietic progenitors of a 32year old male who had coinherited a homozygous β°-thalassemia mutation at codon 41/42 (-TCTT) and a heterozygous α-thalassemia 4.2 deletion. The MUi009-A cell line exhibited embryonic stem cell characteristics with consistent pluripotency marker expression and the capability of differentiating into the three germ layers. The cell line may provide a tool for drug testing and gene therapy studies.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28395745 DOI: 10.1016/j.scr.2017.02.012
Source DB: PubMed Journal: Stem Cell Res ISSN: 1873-5061 Impact factor: 2.020